Sullivan & Cromwell Reps Valeant In $5.7B Cephalon Bid
Valeant Pharmaceuticals International Inc. on Tuesday announced a $5.7 billion bid to buy Cephalon Inc., making a public appeal to the biopharmaceutical company's shareholders....To view the full article, register now.
Already a subscriber? Click here to view full article